Crossmark

Insights on the therapeutic potential of fibrinolytic enzymes, emphasis on Nattokinase and its enhanced production using advanced technologies: a critical review

Crossref DOI link: https://doi.org/10.1007/s42452-025-07102-1

Published Online: 2025-06-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ashokan, Anju Kanjirakandi

Mohanasrinivasan, V.
Funding

Funding for this research was provided by:

Vellore Institute of Technology, Vellore
License Information

Text and Data Mining valid from 2025-06-17

Version of Record valid from 2025-06-17
More Information

Article History

Received: 25 September 2024

Accepted: 7 May 2025

First Online: 17 June 2025

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below